Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Biotec Pharmacon ASA

Closing information (x1000 NOK)

Closing information 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Turnover 84,395 Less Arrow 72,817 Less Arrow 72,758
Financial expenses 811 Less Arrow 0 More Arrow 695
Earnings before taxes -5,926 Less Arrow -13,828 Less Arrow -24,803
Total assets 77,608 Less Arrow 68,015 Less Arrow 61,684
Current assets 58,590 Less Arrow 55,867 Less Arrow 49,967
Current liabilities 18,368 Less Arrow 14,117 More Arrow 16,870
Equity capital 46,476 More Arrow 53,898 Less Arrow 44,813
- share capital 48,335 Equal arrow 48,335 Less Arrow 43,945
Employees (average) 38 More Arrow 43 More Arrow 44
Shareholders 0 0 0

Financial ratios

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Solvency 59.9% More Arrow 79.2% Less Arrow 72.6%
Turnover per employee 2,221 Less Arrow 1,693 Less Arrow 1,654
Profit as a percentage of turnover -7.0% Less Arrow -19.0% Less Arrow -34.1%
Return on assets (ROA) -6.6% Less Arrow -20.3% Less Arrow -39.1%
Current ratio 319.0% More Arrow 395.7% Less Arrow 296.2%
Return on equity (ROE) -12.8% Less Arrow -25.7% Less Arrow -55.3%
Change turnover 11,578 Less Arrow 59 Less Arrow -5,848
Change turnover % 16% Less Arrow 0% Less Arrow -7%
Chg. No. of employees -5 More Arrow -1 Less Arrow -2
Chg. No. of employees % -12% More Arrow -2% Less Arrow -4%

Total value of public sale

Fiscal year 2019/12 (consolidated) 2018/12 (consolidated) 2017/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.